Phages could enable us to hijack vaccine immunity to kill cancer cells

Scientists are exploring the potential of phages, viruses that target bacteria, to revolutionize cancer treatment by leveraging our immune systems primed by vaccines. By genetically engineering these phages, researchers aim to hijack the body's immune response to seek out and destroy cancer cells. This approach could offer a new, less invasive method for treating cancers, potentially reducing the need for chemotherapy and its harsh side effects. The implications are huge, as this method could unlock a powerful new weapon in the fight against various cancers, harnessing something we already have: our vaccine-induced immunity.